Advancements in CRPC Treatment Strategies

This chapter explores the complexities of treating metastatic castrate-resistant prostate cancer (CRPC), focusing on various treatment options and their side effects. It emphasizes the importance of genomic testing, modern strategies such as PARP inhibitors and immunotherapy, and the need for careful monitoring of patient health. Additionally, the chapter discusses the role of clinical trials and emerging therapies, underlining the significance of innovative approaches in improving patient outcomes.